Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Glucocorticoids Plus Rituximab Compared to Glucocorticoids Plus Placebo for the Treatment of Patients With Newly-Diagnosed or Relapsing IgA Vasculitis: A Prospective, Randomized, Controlled, Double-blind Study

NCT05329090 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT05329090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05329090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Glucocorticoids Plus Rituximab Compared to Glucocorticoids Plus Placebo for the Treatment of Patients With Newly-Diagnosed or Relapsing IgA Vasculitis: A Prospective, Randomized, Controlled, Double-blind Study
Lead sponsor
Hopital Foch
Phase
Phase 3
Overall status
Completed
Start date
March 11, 2022
Completion date
January 13, 2026
Enrollment
75 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

iga vasculitis